Stay updated on Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record history now shows a new revision label (v3.6.4) replacing the previous v3.6.3. This indicates a system update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new release entry 'Revision: v3.6.3' has been added to the study's history, and the previous 'Revision: v3.6.0' has been removed. This reflects an update to the page's underlying release notes.SummaryDifference0.1%

- Check46 days agoChange DetectedThe history now shows that recruitment has ended ('No longer looking for participants') and logs a new revision (v3.6.0) while removing the prior revision entry (v3.5.5).SummaryDifference0.4%

- Check53 days agoChange DetectedA new release entry, v3.5.5, appears in the record history, replacing v3.5.4. This indicates a background update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page's Revision label changed from v3.5.3 to v3.5.4 to reflect a new site release; no other study content or details appear to be modified.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page footer’s software/application revision indicator was updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.